Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fuke Duanhongyin Jiao Nang is a Traditional Chinese Medicine (TCM) hospital preparation developed by the Shaoxing Maternity and Child Health Care Hospital. It is primarily indicated for the treatment of abnormal uterine bleeding (AUB), including dysfunctional uterine bleeding and post-procedural hemorrhage. The formulation is a capsule-based adaptation of the traditional 'Duan Hong Yin' decoction, designed to clear heat, cool the blood, and resolve stasis to achieve hemostasis. Its active profile is derived from a combination of herbal ingredients such as Sanguisorba officinalis and Agrimonia eupatoria, which are traditionally used to stabilize the endometrium and reduce excessive menstrual volume. Clinical studies at the developing institution have demonstrated its efficacy in managing bleeding duration and intensity in gynecological patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fuke duan hong yin jiao nang.